{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:39:51Z","timestamp":1759333191516,"version":"3.37.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/shk.0b013e3181a6eaf5","type":"journal-article","created":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T13:32:54Z","timestamp":1260279174000},"page":"93-100","source":"Crossref","is-referenced-by-count":31,"title":["MOLECULAR MECHANISMS OF PROPOFOL-INVOLVED SUPPRESSION OF NO BIOSYNTHESIS AND INDUCIBLE iNOS GENE EXPRESSION IN LPS-STIMULATED MACROPHAGE-LIKE RAW 264.7 CELLS"],"prefix":"10.1097","volume":"33","author":[{"given":"Chao-Jen","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ting","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruei-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210213","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00000542-198908000-00015","article-title":"Propofol: a new intravenous anesthetic.","volume":"71","author":"Sebel","year":"1989","journal-title":"Anesthesiology"},{"key":"R2-16-20210213","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00003246-200003000-00041","article-title":"Sedation in the intensive care unit.","volume":"28","author":"Young","year":"2000","journal-title":"Crit Care Med"},{"key":"R3-16-20210213","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00003495-199550030-00008","article-title":"Propofol. An update of its use in anaesthesia and conscious sedation.","volume":"50","author":"Bryson","year":"1995","journal-title":"Drugs"},{"key":"R4-16-20210213","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1213\/00000539-199809000-00039","article-title":"Propofol inhibits human neutrophil functions.","volume":"87","author":"Mikawa","year":"1998","journal-title":"Anesth Analg"},{"key":"R5-16-20210213","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/00003246-199909000-00023","article-title":"Propofol reduces the migration of human leukocytes through endothelial cell monolayers.","volume":"27","author":"Hofbauer","year":"1999","journal-title":"Crit Care Med"},{"key":"R6-16-20210213","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/00000542-200305000-00021","article-title":"Propofol suppresses macrophage functions through modulating mitochondrial membrane potential and cellular adenosine triphosphate levels.","volume":"98","author":"Chen","year":"2003","journal-title":"Anesthesiology"},{"key":"R7-16-20210213","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1196\/annals.1338.019","article-title":"Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity thus reducing cellular ATP biosynthesis and migration of macrophages.","volume":"1042","author":"Wu","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R8-16-20210213","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.ATV.0000257552.94483.14","article-title":"Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms.","volume":"27","author":"McCormick","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R9-16-20210213","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.taap.2007.11.027","article-title":"Ketamine inhibits tumor necrosis factor- and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of Toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.","volume":"228","author":"Wu","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"R10-16-20210213","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/bja\/68.6.613","article-title":"The antioxidant potential of propofol (2,6-diisopropylphenol).","volume":"68","author":"Murphy","year":"1992","journal-title":"Br J Anaesth"},{"key":"R11-16-20210213","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/bja\/80.5.649","article-title":"Propofol and intralipid interact with reactive oxygen species: a chemiluminescence study.","volume":"80","author":"Demiryurek","year":"1998","journal-title":"Br J Anaesth"},{"key":"R12-16-20210213","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF03017924","article-title":"Therapeutic concentrations of propofol protects mouse macrophages from nitric oxide-induced cell death and apoptosis.","volume":"49","author":"Chang","year":"2002","journal-title":"Can J Anaesth"},{"key":"R13-16-20210213","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1196\/annals.1338.038","article-title":"2,6-Diisopropylphenol protects osteoblasts from oxidative stress-induced apoptosis through suppression of caspase-3 activation.","volume":"1042","author":"Chen","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R14-16-20210213","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity.","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R15-16-20210213","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology.","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol Rev"},{"key":"R16-16-20210213","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/jor.20578","article-title":"Apoptotic insults to human chondrocytes induced by nitric oxide are involved in sequential events, including cytoskeletal remodeling, phosphorylation of mitogen-activated protein kinase kinase kinase-1, and Bax-mitochondria-mediated caspase activation.","volume":"26","author":"Cherng","year":"2008","journal-title":"J Orthop Res"},{"key":"R17-16-20210213","first-page":"73","article-title":"Propofol significantly attenuates iNOS, CAT-2, and CAT-2B transcription in lipopolysaccharide-stimulated murine macrophages.","volume":"44","author":"Liu","year":"2006","journal-title":"Acta Anaesthesiol Twn"},{"key":"R18-16-20210213","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.TA.0000033496.62796.3B","article-title":"Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharide-activated macrophages.","volume":"55","author":"Wu","year":"2003","journal-title":"J Trauma"},{"key":"R19-16-20210213","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.4049\/jimmunol.150.11.5080","article-title":"Nitric oxide-mediated apoptosis in murine peritoneal macrophages.","volume":"150","author":"Albina","year":"1993","journal-title":"J Immunol"},{"key":"R20-16-20210213","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(95)00450-5","article-title":"Cell death induced by -amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis.","volume":"686","author":"Le","year":"1995","journal-title":"Brain Res"},{"key":"R21-16-20210213","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00002371-200005000-00005","article-title":"Intensified regression of colon cancer liver metastases in mice treated with irinotecan and the immunomodulator JBT 3002.","volume":"23","author":"Shinohara","year":"2000","journal-title":"J Immunother"},{"key":"R22-16-20210213","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00204-003-0453-z","article-title":"Propofol downregulates nitric oxide biosynthesis through inhibiting inducible nitric oxide synthase in lipopolysaccharide-activated macrophages.","volume":"77","author":"Chen","year":"2003","journal-title":"Arch Toxicol"},{"key":"R23-16-20210213","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1096\/fasebj.5.12.1916089","article-title":"Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction.","volume":"5","author":"Raetz","year":"1991","journal-title":"FASEB J"},{"key":"R24-16-20210213","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity.","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"R25-16-20210213","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri2038","article-title":"Cooperation of Toll-like receptor signals in innate immune defence.","volume":"7","author":"Trinchieri","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R26-16-20210213","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1189\/jlb.69.6.1036","article-title":"Different Toll-like receptor agonists induce distinct macrophage responses.","volume":"69","author":"Jones","year":"2001","journal-title":"J Leukocyte Biol"},{"key":"R27-16-20210213","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.shk.0000129759.58490.d6","article-title":"Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFB activation.","volume":"22","author":"Fan","year":"2004","journal-title":"Shock"},{"key":"R28-16-20210213","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1242\/jcs.01589","article-title":"AP-1 subunits: quarrel and harmony among siblings.","volume":"117","author":"Hess","year":"2004","journal-title":"J Cell Sci"},{"key":"R29-16-20210213","doi-asserted-by":"crossref","first-page":"28546","DOI":"10.1074\/jbc.M102075200","article-title":"Protective role for c-Jun in the cellular response to DNA damage.","volume":"276","author":"Potapova","year":"2001","journal-title":"J Biol Chem"},{"key":"R30-16-20210213","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0006-291X(02)00283-8","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1\/MEK4\/JNK signaling pathway in endotoxin-activated microglia.","volume":"293","author":"Delgado","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"R31-16-20210213","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","article-title":"Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.","volume":"37","author":"Paik","year":"2003","journal-title":"Hepatology"},{"key":"R32-16-20210213","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/intimm\/dxg126","article-title":"Dominant-negative effect of the c-fos family gene products on inducible NO synthase expression in macrophages.","volume":"15","author":"Okada","year":"2003","journal-title":"Intl Immunol"},{"key":"R33-16-20210213","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1213\/00000539-198712000-00010","article-title":"Disposition of propofol administered as constant rate intravenous infusions in humans.","volume":"66","author":"Gepts","year":"1987","journal-title":"Anesth Analg"},{"key":"R34-16-20210213","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.taap.2006.11.031","article-title":"Oxidized low-density lipoprotein induces apoptotic insults to mouse cerebral endothelial cells via a Bax-mitochondria-caspase protease pathway.","volume":"219","author":"Chen","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"R35-16-20210213","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/jor.20244","article-title":"Nitric oxide protects osteoblasts from oxidative stress-induced apoptotic insults via a mitochondria-dependent mechanism.","volume":"24","author":"Chang","year":"2006","journal-title":"J Orthop Res"},{"key":"R36-16-20210213","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jor.20365","article-title":"Pretreatment with low nitric oxide protects osteoblasts from high nitric oxide-induced apoptotic insults through regulation of c-Jun N-terminal kinase\/c-Jun-mediated Bcl-2 gene expression and protein translocation.","volume":"25","author":"Tai","year":"2007","journal-title":"J Orthop Res"},{"key":"R37-16-20210213","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/jcb.21268","article-title":"Nitric oxide from both exogenous and endogenous sources activates mitochondria-dependent events and induces insults to human chondrocytes.","volume":"101","author":"Wu","year":"2007","journal-title":"J Cell Biochem"},{"key":"R38-16-20210213","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-2478(94)00157-X","article-title":"Regulation of nitric oxide synthesis in infectious and autoimmune diseases.","volume":"43","author":"Liew","year":"1994","journal-title":"Immunol Lett"},{"key":"R39-16-20210213","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00011-006-5116-0","article-title":"Protective effects of propofol on lipopolysaccharide-activated endothelial cell barrier dysfunction.","volume":"55","author":"Gao","year":"2006","journal-title":"Inflamm Res"},{"key":"R40-16-20210213","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2006.07.013","article-title":"Halothane induces oxidative stress and NFB activation in rat liver: protective effect of propofol.","volume":"227","author":"Brasil","year":"2006","journal-title":"Toxicology"},{"key":"R41-16-20210213","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1074\/jbc.M309525200","article-title":"RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity.","volume":"279","author":"Gallagher","year":"2004","journal-title":"J Biol Chem"},{"key":"R42-16-20210213","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","article-title":"Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR 4 as the LPS gene product.","volume":"162","author":"Hoshino","year":"1999","journal-title":"J Immunol"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SHK.0b013e3181a6eaf5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T18:00:49Z","timestamp":1739469649000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00024382-201001000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e3181a6eaf5","relation":{},"ISSN":["1073-2322"],"issn-type":[{"type":"print","value":"1073-2322"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}